Reuters logo
BRIEF-Tetraphase Pharmaceuticals signs commercial supply agreement with Finorga
October 20, 2017 / 8:31 PM / 2 months ago

BRIEF-Tetraphase Pharmaceuticals signs commercial supply agreement with Finorga

Oct 20 (Reuters) - Tetraphase Pharmaceuticals Inc:

* Tetraphase Pharmaceuticals Inc says ‍on October 16 co and finorga sas entered into a commercial supply agreement​ - sec filing

* Tetraphase Pharmaceuticals - ‍under supply agreement finorga sas will make for commercial supply active pharmaceutical ingredient for eravacycline for co​

* Tetraphase Pharmaceuticals- ‍supply agreement has initial term ending Oct 16, 2022 Source text - bit.ly/2yE5byE Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below